Patent · US Expired

Human pelota homolog

US5925539A · kind A · utility

1Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 2, 1998
Grant dateJul 20, 1999
Priority date
Expiry dateSep 2, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.